N0539 Phase II Trial of Fulvstrant and Bevacizumab in Patients with Metastatic Breast Cancer Previously Treated with an Aromatase Inhibitor: A North Central Cancer Treatment Group Trial.
- Citation:
- Cancer Res vol 69 (24 suppl 3) abstr 738S
- Meeting Instance:
- SABCS 2009
- Year:
- 2009
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- W. W. Tan A. C. Dueck P. Flynn P. Steen D. Anderson K. Rowland Jr D. Nothfeldt W. Lingle J. Copland E. A. Perez
- Networks:
- Study
- NCCTG-N0539
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: